Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial
Latest Information Update: 04 Aug 2023
Price :
$35 *
At a glance
- Drugs Toripalimab (Primary) ; Cisplatin
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 16 Aug 2021 Planned number of patients changed from 80 to 40.
- 11 Aug 2021 New trial record